Category:

Non-Life

Aviation reinsurance rates rise by up to 250% – report

Insurers and reinsurers face claims from the crashes relating to hull and product liability that could amount to more than $2 billion, a large sum in a relatively small insurance sector, Willis Re International chair James Vickers told Reuters.

Aviation underwriters are also suffering from lower premiums due to worldwide lockdowns and travel bans, as insurance contracts are often negotiated based on the amount of time planes spend in the air.

read more

S. African insurers may fund vaccines for broader population

Legislation has been amended to allow the companies to fund shots for people who don’t have medical insurance and talks are now focused on the number of those who may benefit, said Stavros Nicolaou, head of the Health Workgroup for B4SA, a grouping of South Africa’s biggest business organizations. In addition to medical insurers, companies such as miners may contribute funds so their workers can be covered, he said.

read more

Global Covid-19 cases surpass 85 million mark: Johns Hopkins University

The US is the worst-hit country with the world’s highest number of cases and deaths at 20,626,686 and 351,453, respectively, according to the CSSE.

India comes in second place in terms of cases at 10,323,965, while the country’s death toll soared to 149,435.
Brazil currently accounts for the second highest number of fatalities at 196,018.

read more

1 Jan renewals:Reinsurers arrest downward pricing, say no to ongoing Contagious Disease exposures

Improving investment markets, retained earnings and newly raised capital helped global reinsurance capital levels to recover rapidly during 2020, ending the year 3% higher than at year-end 2019.

For buyers, terms and conditions have overall been less onerous than initially feared again revealing the efficient working of the global reinsurance market,

Emerging COVID-19 losses, often advised only late in the renewal process or yet to be advised, triggered technical discussions of primary policy coverage and reinsurance treaty wordings.
Both remain in the early stages of deliberation, so, sensibly, most programmes renewed without considering any potential COVID-19 losses, leaving time for more measured discussions and subsequent adjustments.

read more

India bars virus vaccine maker from exporting

The company also has been barred from selling the vaccine on the private market.

As a result, Adar Poonawalla, Serum Institute’s  CEO said, the export of vaccines for COVAX — the ambitious initiative created to ensure equitable access to COVID-19 vaccines set up by the World Health Organization, vaccines alliance GAVI and CEPI, a global coalition to fight epidemics — won’t begin until March or April.

read more